{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:lymphatic:lymph-008-staging-ISL",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-07T00:35:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent",
      "quality-enhancement-agent"
    ],
    "confidence": 0.95,
    "status": "peer-reviewed",
    "last_updated": "2026-01-07T00:35:00.000Z",
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/lymphatic",
    "type": "classification",
    "difficulty": "intermediate",
    "importance": "critical",
    "aku_id": "LYMPH-008",
    "keywords": [
      "lymphedema staging",
      "ISL staging",
      "lymphedema classification",
      "lymphedema severity"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "lymphatic_disease",
    "isNativeDomain": true
  },
  "content": {
    "statement": "vascular:lymphatic:lymph-008-staging-ISL is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Lymphatic that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:lymphatic:lymph-008-staging-ISL helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:lymphatic:lymph-008-staging-ISL include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:lymphatic:lymph-008-staging-ISL."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "clinical_features": {
    "staging_system": {
      "Stage_0": {
        "name": "Latent/Subclinical",
        "description": "Impaired lymphatic transport without clinical edema",
        "clinical_features": "No visible swelling, may have subjective heaviness",
        "diagnosis": "Lymphoscintigraphy abnormal, bioimpedance spectroscopy detects early changes",
        "reversibility": "Not applicable - no visible edema",
        "treatment": "Surveillance, risk reduction counseling, consider prophylactic compression"
      },
      "Stage_I": {
        "name": "Reversible/Mild",
        "description": "Accumulation of protein-rich fluid that reduces with elevation",
        "clinical_features": "Soft pitting edema, resolves overnight or with elevation",
        "diagnosis": "Clinical examination, limb volume measurement",
        "reversibility": "Reversible with elevation",
        "treatment": "Complete decongestive therapy (CDT), compression garments, exercise"
      },
      "Stage_II": {
        "name": "Spontaneously Irreversible/Moderate",
        "description": "Limb elevation alone rarely reduces swelling",
        "clinical_features": "Tissue fibrosis developing, may be pitting (IIa) or non-pitting (IIb)",
        "substages": "IIa - pitting present; IIb - non-pitting, brawny texture",
        "diagnosis": "Clinical examination, circumference/volume increase 20-40%",
        "reversibility": "Does not reverse with elevation alone",
        "treatment": "Intensive CDT phase 1, then maintenance phase 2, consider surgery"
      },
      "Stage_III": {
        "name": "Lymphostatic Elephantiasis/Severe",
        "description": "Massive swelling with trophic skin changes",
        "clinical_features": "Papillomatosis, hyperkeratosis, folds, lymphorrhea",
        "skin_changes": "Warty projections, thickened leathery skin, deep folds",
        "diagnosis": "Clinical, may have >40% volume increase",
        "reversibility": "Significant reduction possible but residual deformity",
        "treatment": "Intensive CDT, debulking surgery, skin care, wound management"
      }
    },
    "additional_classification": {
      "severity_by_volume": {
        "mild": "<20% excess limb volume",
        "moderate": "20-40% excess limb volume",
        "severe": ">40% excess limb volume"
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "ISL Lymphedema Staging"
    },
    "altLabel": [
      "International Society of Lymphology staging",
      "Lymphedema severity classification"
    ],
    "definition": {
      "@language": "en",
      "@value": "A standardized clinical staging system for lymphedema from Stage 0 (latent) through Stage III (lymphostatic elephantiasis) based on reversibility, tissue consistency, and skin changes."
    },
    "notation": "LYMPH-008"
  },
  "relationships": {
    "prerequisites": [
      "vascular:lymphatic:lymph-001-definition"
    ],
    "enables": [
      "vascular:lymphatic:lymph-009-complete-decongestive-therapy"
    ],
    "skos:broader": [
      "vascular:staging-systems"
    ],
    "skos:related": [
      "vascular:venous:ceap-classification"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Concept"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). vascular:lymphatic:lymph-008-staging-ISL. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "pedagogical": {
    "target_audience": [
      "vascular surgery residents",
      "lymphedema therapists",
      "physical therapists"
    ],
    "estimated_time": "15min",
    "learning_objectives": [
      "Describe the ISL staging system for lymphedema",
      "Differentiate clinical features of each stage",
      "Understand the concept of Stage 0 (latent) lymphedema",
      "Match treatment intensity to disease stage"
    ],
    "clinical_pearls": [
      "Stage 0 represents the WINDOW OF OPPORTUNITY - early detection allows early intervention",
      "Bioimpedance spectroscopy can detect Stage 0 before visible swelling",
      "Pitting vs non-pitting distinguishes Stage IIa from IIb",
      "Stage III elephantiasis includes trophic skin changes (papillomatosis, hyperkeratosis)",
      "Treatment intensity escalates with stage - early treatment prevents progression"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "codingSystem": "SNOMED-CT",
      "codeValue": "234097001",
      "description": "Secondary lymphedema"
    },
    {
      "codingSystem": "ICD-10-CM",
      "codeValue": "I89.0",
      "description": "Lymphedema, not elsewhere classified"
    }
  ],
  "owl:sameAs": "http://dbpedia.org/resource/Concept",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}